Early intervention with hormone optimization, metabolic support, anti-inflammatory nutrition, and targeted exercise can reverse early insulin resistance and dramatically reduce the risk of chronic disease down the road
has received honoraria for lectures, received scholarship grants, and received research grant from Novo Nordisk Pharma, Sanofi, Eli Lilly, Boehringer Ingelheim, Taisho Pharma, Sumitomo Dainippon Pharma, Takeda Pharma, Ono Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Kissei Pharma, MSD, AstraZeneca, Astellas, Novartis, Kowa, Abbott
Int J Cancer (2008) 122:10828
The new labeling information contains the warning of increased risk of pancreatitis for patients taking Zepbound